Device and application security leader Trustonic has announced that OPTOLANE has selected Trustonic Secured Platform (TSP) to bring security and trust to the company´s new connected medical diagnostic device, the company said.
The product is primarily used at the point-of-care for early diagnosis and preventative healthcare, particularly for diagnosing cancer, infectious diseases and congenital abnormalities.
Healthcare devices have become top targets for cybercriminals due to their critical nature, the valuable intellectual property they employ and the sensitive personal information that they collect and store. Research shows that there were 8.2 attempted cyberattacks per connected healthcare endpoint in each month of 20181.
To ensure security, privacy and high performance, OPTOLANE´s simple, fast and smart diagnostic platform is based on Nexell´s system on chip (SoC) platform, which integrates Trustonic´s Trusted Execution Environment (TEE)*. OPTOLANE´s in vitro diagnostic (IVD) platform, called LOAA (Lab on an Array) Analyzer, examines blood and tissue samples for multiple targets, including DNA, RNA, proteins and metabolites, in real-time. It was developed to satisfy market demand for ´sample to answer´ IVD tools and enables sample extraction through to analysis with a single cartridge.
